CTSB and neoplasm: For instance, cAC10-vcMMAE, constructed with anti-CD30 monoclonal antibody (cAC10), cathepsin B-specific cleavable valine-citrulline (VC) dipeptide linker, and MMAE, has shown highly selective therapy for the tumor treatment with minimized toxicity [18].